Abstract
Objective: To understand the effect of obesity and insulin on immune functions in non-insulin-dependent diabetes mellitus (NIDDM).
Subject: Fourteen obese NIDDM (body mass index (BMI)=30.6±1.1), seven non-obese NIDDM (BMI=24.2±0.5) and five obese non-NIDDM (BMI=28.3±0.67).
Interventions: We first examined the influence of insulin on the proliferation of several human cell lines. Second, we compared several immune functions between obese and non-obese NIDDM, and obese non-NIDDM patients using peripheral blood mononuclear cells.
Result: Insulin decreased proliferation of T-cell lines but not that of other types of cell lines. Furthermore, obesity augmented the production of IL-1β which could have cytotoxity against islet β cells in NIDDM.
Conclusion: Our data suggested that the pathophysiology of NIDDM could be affected by the change of immunity due to obesity, and the treatment of obesity in NIDDM may be important from an immunological aspect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brinkmann V, Kristofic C . 1995 Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO− and CD45RO+subsets J. Immunol. 155: 3322–3328
Bunout D, Munoz C, Lopez M, de la Maza MP, Schlesinger L, Hirsch S, Pettermann M . 1996 Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients Am. J. Clin. Nutr. 63: 373–376
Ciampolillo A, Guastamacchia E, Caragiulo L, Lollino G, Robertis OD, Lattanzi V, Giorgino R . 1993 In vitro secretion of interleukin-1β and interferon-γ by peripheral blood lymphomononuclear cells in diabetic patients Diabetes Res. Clin. Pract. 21: 87–93
Clausell N, Kalil P, Biolo A, Molossi S, Azevedo M . 1999 Increased expression of tumor necrosis factor-alpha in diabetic macrovasculopathy Cardiovasc. Pathol. 8: 145–151
Considine RV, Sinbe MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, Mckee LJ, Bauer TL, Garo JF . 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans New Engl. J. Med. 334: 292–295
Davaraj S, Jialal I . 2000 Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation Circulation 102: 191–196
Dinarello C . 1984 Interleukin-1 and the pathogenesis of the acte-phase response New Engl. J. Med. 311: 1413–1418
Dinarello C, Mier J . 1987 Lymphokines New Engl. J. Med. 317: 940–945
Feng-Yee C, Men-Fang S . 1995 Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus Diabetes Res. Clin. Pract. 28: 137–146
Frederichi RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS . 1995 Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action Nature Med. 1: 1311–1314
Helderman JH . 1981 Role of insulin in the intermediary metabolism of activated thymic-derived lymphocyte J. Clin. Invest. 67: 1636–1642
Helderman JH, Raskin P . 1980 The T lymphocyte insulin receptor in diabetes and obesity: an intrinsic binding defect Diabetes 29: 551–557
Holden RJ, Mooney PA . 1995 Interleukin-1β: a common cause of Alzheimer's disease and diabetes mellitus Med. Hypotheses 45: 559–571
Hunt P, Eardley D . 1986 Suppressive effects of insulin and insulin-like growth factor-1 (IGF1) on immune responses J. Immunol. 136: 3994–3999
Kappel M, Dela F, Barington T, Galbo H, Pedersen BK . 1998 Immunological effects of a hyperinsulinaemic euglycaemic insulin clamp in healthy males Scand. J. Immunol. 47: 363–368
Kiess W, Belohradsky BH . 1986 Endocrine regulation of the immune system Klin. Wochenschr. 64: 1–7
Loffreda S, Yang SQ, Lin HZ, Karp GL, Brengman ML, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD . 1998 Leptin regulates proinflammatory immune responses F.A.S.E.B. J. 12: 57–65
Lord GM, Matares G, Howard JK, Baker RJ, Bloom SR, Lechler RI . 1998 Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression Nature 394: 897–901
Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello C, Svenson M, Nielsen J . 1986 Affinity purified human Interleukin-1 is cytotoxic to isolated islet of Langherans Diabetologia 29: 63–67
Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V . 2000 Human leptin enhances activation and proliferation of human circulating T lymphocytes Cell Immunol. 199: 15–24
Mito N, Hosoda T, Chiaki K, Sato K . 2000 Change of cytokine balance in diet-induced obese mice Metabolism 49: 1295–1300
Mohamed-Ali V, Pinkney J, Coppack S . 1998 Adipose tissue as an endocrine and paracrine organ Int. J. Obes. Relat. Metab. Disord. 22: 1145–1158
Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC . 1999 Influence of obesity on immune function J. Am. Diet. Assoc. 99: 294–299
Plouffe JF, Silva J Jr, Fekety R, Allen JL . 1978 Cell-mediated immunity in diabetes mellitus Infect. Immun. 21: 425–429
Reyzelman A, Lipsky B, Hadi S, Harkless L, Armstrong D . 1999 The increased prevalence of severe nercotizing infections caused by non-group A streptococci J. Am. Podiat. Med. Assoc. 89: 454–457
Santos-Alvarez J, Goberna R, Sanchez-Margalet V . 1999 Human leptin stimulates proliferation and activation of human circulating monocytes Cell Immunol. 194: 6–11
Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, Sugiyama A, Takamura Y, Okuda K . 1993 Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness Int. J. Obes. Relat. Metab. Disord. 17: 631–636
Tanaka S, Isoda F, Yamakawa T, Ishihara M, Sekihara H . 1998 T lymphopenia in genetically obese rats Clin. Immunol. Immunopathol. 86: 219–225
Varner AE . 2000 An immunologic mechanism for the association between obesity and asthma Arch. Intern. Med. 160: 2395
Acknowledgements
The authors thank M Abe for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mito, N., Hiyoshi, T., Hosoda, T. et al. Effect of obesity and insulin on immunity in non-insulin-dependent diabetes mellitus. Eur J Clin Nutr 56, 347–351 (2002). https://doi.org/10.1038/sj.ejcn.1601324
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601324
Keywords
This article is cited by
-
Systemic immunity of obese-diabetes model (db/db) mice
Molecular & Cellular Toxicology (2010)
-
Long term effects of high fat and sucrose diets on obesity and lymphocyte proliferation in mice
The Journal of nutrition, health and aging (2009)
-
Obesity, anemia, and cardiovascular risk in patients with chronic kidney disease: Overview and pathophysiologic insights
Current Cardiovascular Risk Reports (2009)
-
Decreased splenic mRNA expression levels of TNF-α and IL-6 in diet-induced obese animals
Journal of Physiology and Biochemistry (2004)